Comparative analysis of social and economic efficiency in managing product innovations in the pharmaceutic industry

Journal of Entrepreneurship and Sustainability Issues, 2020

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.9770/jesi.2020.8.2(74)
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Despite the variety of studies of modern innovative projects within the global pharmaceutical industry, the study of the management system for innovative projects in the pharmaceutical industry is relevant.The pharmaceutical business has a high social role in the country's economy, meeting the needs of the population in providing the necessary products.This is what determines the significant influence of the state on this sphere of economic activity, which is expressed in the mandatory fulfillment of a number of rigidly and clearly established requirements, due to which the observance of the rights of citizens in the possibility of obtaining high-quality pharmaceutical products will be ensured.The aim of the study is to consider the socio-economic characteristics of managing product innovations in pharmaceuticals (leading pharmaceutical markets) based on assessing the level of innovative activity of pharmaceutical companies, which addresses the problems of managing their role and importance in the healthcare system of Kazakhstan.